3.80
price down icon2.06%   -0.08
after-market 시간 외 거래: 3.75 -0.05 -1.32%
loading

Larimar Therapeutics Inc (LRMR) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
10.89%
27.79
31.19 31.29 18.26 24.60
Operating Income/Loss
10.89%
-27.79
-31.19 -31.29 -18.26 -24.60
Nonoperating Income/Loss
15.57%
1.61
1.907 2.469 2.765 2.972
Income/Loss From Continuing Operations Before Tax
10.58%
-26.18
-29.28 -28.82 -15.50 -21.63
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
10.58%
-26.18
-29.28 -28.82 -15.50 -21.63
Net Income/Loss
10.58%
-26.18
-29.28 -28.82 -15.50 -21.63
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.10%
64.03
63.96 0.8564 63.81 63.80
Diluted Average Shares
0.10%
64.03
63.96 0.8564 63.81 63.80
Basic Earnings Per Share
10.87%
-0.41
-0.46 -0.46 -0.24 -0.34
Diluted Earnings Per Share
10.87%
-0.41
-0.46 -0.46 -0.24 -0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
자본화:     |  볼륨(24시간):